Full-Time

Research Nurse

Posted on 2/21/2026

Tennessee Oncology

Tennessee Oncology

501-1,000 employees

Community-based cancer care with clinical research

No salary listed

Nashville, TN, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Required Skills
Inventory Management
Google Cloud Platform
Requirements
  • RN License
  • An Associate Degree; preferably a bachelor’s degree
  • At least one year of oncology experience
  • At least one year of experience in a research setting (preferred)
  • Knowledge of FDA Code of Federal Regulations and Good Clinical Practice
  • Knowledge of the clinical research processes
  • Knowledge of medical and research terminology
  • Ability to work independently while collaborating effectively with a multidisciplinary team
  • Strong attention to detail and organizational skills
Responsibilities
  • Enroll patients onto clinical trials through recruitment, screening, enrollment, treatment, and follow-up of eligible participants according to protocol requirements.
  • Provide thorough education about study requirements and expectations.
  • Complete and document the informed consent process accurately, ensuring all parties sign and date as required, including obtaining HIPAA Authorization.
  • Obtains and maintains informed consents of each patient for the duration of a study.
  • Review the study design and inclusion/exclusion criteria with physician and patient.
  • Complete and submit on-study forms within required timelines.
  • Maintain accurate and detailed source documentation, including study visits findings, and outcomes.
  • Screen all new patients or patients returning to office with scan results and document appropriately on patient tracking logs.
  • Monitor subjects throughout the study, ensuring compliance with protocols and maintaining patient safety.
  • Ensure that all medications are approved prior to initiating treatment or when changing medication regimens, such as crossover studies.
  • Dispense oral investigational products to study participants and provide guidance to ensure compliance with medication regimens.
  • Accurately calculate and document BSA, Creatinine Clearance, Urine Protein: Creatinine ratio, and any other calculations or conversions required per protocol.
  • Ensure that follow-up appointments, scans, or related procedures are scheduled correctly according to protocol requirements.
  • Record and report adverse events in accordance with study protocols and regulatory requirements.
  • Document appropriately when patients are removed from protocol.
  • Ensure reconsent of patients at the next scheduled visit, following availability of updated ICF, and documents process appropriately.
  • Provide patient education and medical information to study patients to ensure understanding or proper medication dosage, administration, and disease treatment.
  • Maintains medication inventory and reconciliation.
  • Collaborate with the clinical research team to ensure timely completion of study-related tasks and reporting.
  • Serve as a liaison between study participants, investigators, and the research team to address questions and concerns.
  • Float to other research Tennessee Oncology clinics as needed
Desired Qualifications
  • Research Certification (ACRP or CCRP) Preferred

Tennessee Oncology runs a large network of community-based cancer care with a strong clinical-trial program. It delivers cancer treatment at local clinics, including on-site chemotherapy, and uses molecular diagnostics to tailor therapies to each patient’s cancer. The organization supports patients with its in-house Park Pharmacy, which stocks oncology and hematology medications and handles insurance, prior authorizations, co-pays, and 24/7 pharmacist access. It differentiates itself by combining extensive community-based care with a sizable research network and a partnership with OneOncology, enabling broad access to trials and advanced care at convenient locations. The goal is to provide high-quality cancer care and access to clinical research close to patients’ homes.

Company Size

501-1,000

Company Stage

Debt Financing

Total Funding

$98.3M

Headquarters

Nashville, Tennessee

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Opened Johnson City clinic November 5, 2024, staffed by Drs. Maatouk and Lord.
  • Partnered with OncoveryCare post-$4.5M funding for survivorship care model.
  • Launched rural telehealth program in Dickson and Robertson Counties.

What critics are saying

  • Ascension's Drs. Waynick and Mitchell steal Tullahoma patients within 6-12 months.
  • SOPHiA GENETICS rivals erode precision medicine edge in 12-24 months.
  • One Oncology acquires practices, forcing Tennessee Oncology sale in 12-18 months.

What makes Tennessee Oncology unique

  • Tennessee Oncology integrates medical oncology, radiation oncology, and imaging at Tullahoma center.
  • Appointed Dr. Casey Chollet-Lipscomb as Chief Medical Officer on March 10, 2025.
  • Expanded SOPHiA GENETICS partnership for precision medicine across 36 clinics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Paid Vacation

Flexible Work Hours

Company News

Tennessee Oncology
Sep 24th, 2025
Tennessee Oncology Breaks Ground on State-of-the-Art Medical Center in Tullahoma

Tennessee Oncology breaks ground on state-of-the-art Medical Center in Tullahoma. Tennessee Oncology recently broke ground a new state-of-the-art medical center in Tullahoma. Located on a three-acre campus, the 33,000 square foot center will bring together medical oncology, radiation oncology, and imaging services - offering patients comprehensive, coordinated cancer care in one location, close to home. "The official groundbreaking of the Tullahoma Medical Center is more than the start of construction - it is a continuation of a mission, a vision, and a legacy of compassionate care for the Tullahoma community," said Natalie Dickson, MD, President and CEO of Tennessee Oncology. "This new facility represents a bold step forward for Tullahoma. Together, with Dr. Ryan Carr, Dr. Nnamdi Eze, Dr. John Phillips, Dr. Brian Schlick, and Dr. Mark Sittig, we are laying the foundation for something that will make a lasting impact. This center will not only provide critical care to patients, but it will also stand as a symbol of hope, healing, and the enduring strength of this community." The Tullahoma Medical Center is a continuation of the incredible legacy of Dr. Mainuddin Ahmed and Dr. Adil Mohyuddin, whose commitment to oncology care in the Tullahoma region laid the foundation for the care Tnoncology provide patients today. This new medical center represents the heart of its mission at Tennessee Oncology - bringing world-class cancer care closer to the communities that need it most. Its investment in the Tullahoma Medical Center reflects its commitment to expanding access, supporting local patients, and delivering compassionate care where it matters. Tennessee Oncology extends a sincere thank-you to Jason Quick, the Tullahoma City Administrator, and Kathryn Wiseman of the Tullahoma Area Chamber of Commerce. Their dedication to the community and support of this project have been instrumental.

PR Newswire
Mar 10th, 2025
Tennessee Oncology Appoints Dr. Casey Chollet-Lipscomb As Chief Medical Officer

NASHVILLE, Tenn., March 10, 2025 /PRNewswire/ -- Tennessee Oncology, a nationally recognized independent oncology practice that treats nearly half of the cancer patients in the state across 36 clinics, is pleased to announce the appointment of Casey Chollet-Lipscomb, MD, as its new Chief Medical Officer

PR Newswire
Dec 3rd, 2024
Oneoncology Partner Practice Investigators To Present 26 Abstracts At Ash Annual Meeting

NASHVILLE, Tenn., Dec. 3, 2024 /PRNewswire/ -- OneOncology, a physician-led platform dedicated to advancing independent community oncology practices, and the OneOncology Research Network (OneR), its clinical research site management organization, proudly recognize the outstanding research contributions of its partner practice investigators from The Cancer and Hematology Centers in Michigan, New York Cancer Blood Specialists and Tennessee Oncology, who will showcase a total of 26 oral and poster presentations at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place December 7–10, 2024

Impact Newswire
Nov 22nd, 2024
SOPHiA GENETICS Announces Expanded Partnership with Tennessee Oncology

SOPHiA GENETICS announces expanded partnership with Tennessee Oncology.

PR Newswire
Nov 5th, 2024
Tennessee Oncology Expands Cancer Care With New Clinic In Johnson City

NASHVILLE, Tenn., Nov. 5, 2024 /PRNewswire/ -- Tennessee Oncology, a nationally recognized independent oncology practice that cares for nearly half of Tennessee's cancer patients across 36 locations, proudly announces the opening of its new cancer care center in Johnson City. The clinic will be staffed by Jamal Maatouk, MD, Teresa Lord, MD, and a dedicated 30-member care team. "Expanding access to cancer care in Johnson City enables Tennessee Oncology to deliver world-class cancer treatment to the Tri-Cities region, eliminating the need for patients to travel long distances for the same high-quality care as they would receive in Nashville or Chattanooga," said Natalie Dickson, MD, President and Chief Executive Officer of Tennessee Oncology. "We are thrilled to welcome Dr. Maatouk and Dr

INACTIVE